Cel
SaveMe project will address current urgent needs for pancreatic cancer diagnosis and treatment by exploiting partners’ expertise and most recent research achievements for the design and development of novel modular nanosystems platform integrating new functionalized nano-core particles and active agents. The modular platform will enable the design of diverse active nanosystems per diagnostic or therapeutic application as defined by their active agent compositions. For diagnostics, superior tracers will be developed for molecular MR/PET and gamma camera imaging, enabling efficient diagnosis and guided surgery respectively. Novel functionalized nano-core systems will be conjugated with semi-confluent active shell layer. Three types of shell layers will be design: (1) novel iron oxide nanoparticles as advanced MRI contrast agents and/or (2) DOTA complexes for MRI (with Gd3+), or PET (with Ga-68), or gamma camera (with Ga-69); (3) Integrating within one tracer both iron oxide nanoparticles and DOTA-Ga-68 complexes for a sequential or simultaneous MR/PET imaging. For therapeutics, active nanosystems will be developed to deliver (1) therapeutic siRNAs or (2) anti-MP-inhibitory-scFVs. These non-classic anti-tumor drugs will be designed based on an extensive tumor degradome analysis for combining blockage of selective matrix MPs, thus preventing basic invasive and metastasis steps, with siRNA based neutralization of secondary molecular effects induced by the specific protease inhibition. Individualized degradome analysis will be developed for potential profiling of anti-MP and siRNAs based therapy per patient. To facilitate the above diagnostics and therapeutic effects, advanced tumor targeting and penetration active agents will be linked to nano-core functionalized groups, including a biocompatible PEG layer linked to tumor selective MMP substrate molecules and highly safe and potent novel somatostatin analogue peptides targeting SSTR overexpression.
Dziedzina nauki
- medical and health sciencesclinical medicinesurgery
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensors
- medical and health sciencesclinical medicineradiologynuclear medicine
- engineering and technologynanotechnologynano-materials
- medical and health sciencesclinical medicineoncologypancreatic cancer
Zaproszenie do składania wniosków
FP7-NMP-2010-LARGE-4
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
69978 Tel Aviv
Izrael
Zobacz na mapie
Uczestnicy (22)
1160 WIEN
Zobacz na mapie
69120 Heidelberg
Zobacz na mapie
52900 Ramat Gan
Zobacz na mapie
40126 Bologna
Zobacz na mapie
60323 Frankfurt Am Main
Zobacz na mapie
115193 MOSKVA
Zobacz na mapie
20014 San Sebastian
Zobacz na mapie
20009 San Sebastian
Zobacz na mapie
Zakończenie uczestnictwa
50059 SOVIGLIANA VINCI
Zobacz na mapie
52621 Ramat Gan
Zobacz na mapie
NR4 7TJ Norwich
Zobacz na mapie
81675 Muenchen
Zobacz na mapie
3000 Leuven
Zobacz na mapie
7610001 Rehovot
Zobacz na mapie
117997 MOSCOW
Zobacz na mapie
Zakończenie uczestnictwa
W13 0BY London
Zobacz na mapie
20139 MILANO MI
Zobacz na mapie
Zakończenie uczestnictwa
752 28 Uppsala
Zobacz na mapie
7608665 Rehovot
Zobacz na mapie
75183 UPPSALA
Zobacz na mapie
SO15 2BG SOUTHAMPTON
Zobacz na mapie
50053 Sovigliana
Zobacz na mapie